A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects

Regulatory Toxicology and Pharmacology

Volumn 74, Issue , 2016, Pages 193-199

  Walele, Tanvir ^a   Sharma, Girish ^c   Savioz, Rebecca ^d   Martin, Claire ^d   Williams, Josie ^b  

^a Fontem Ventures   (Netherlands)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SIMBEC RESEARCH LTD   (United Kingdom)

^d Clinopsis SA   (Switzerland)

Author keywords

Adverse events; Cigarette; Clinical study; Electronic cigarette; Electronic vapour product; Nicotine inhalator; Smoking urges; Withdrawal symptoms

Indexed keywords

CARBON MONOXIDE; NICOTINE; NICOTINIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DEVICE SAFETY; DIZZINESS; ELECTRONIC CIGARETTE; FATIGUE; GLOSSODYNIA; HEADACHE; HUMAN; HUMAN EXPERIMENT; INHALER; MALE; MYALGIA; NICOTINE INHALATOR; NICOTINE REPLACEMENT THERAPY; NORMAL HUMAN; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SMOKING; SMOKING URGE; THROAT IRRITATION; TOOTH PAIN; UNITED KINGDOM; VITAL SIGN; WITHDRAWAL SYNDROME; ADVERSE EFFECTS; BREATH ANALYSIS; COMPARATIVE STUDY; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; NEBULIZER; PREVENTION AND CONTROL; PROCEDURES; PRODUCT SAFETY; PSYCHOLOGY; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTOR; TOBACCO USE DISORDER; VOLATILIZATION; WALES; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADULT; AGED; BREATH TESTS; CARBON MONOXIDE; CONSUMER PRODUCT SAFETY; CROSS-OVER STUDIES; ELECTRONIC CIGARETTES; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NICOTINE; NICOTINIC AGONISTS; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TOBACCO USE DISORDER; VOLATILIZATION; WALES; YOUNG ADULT;

EID: 84953361726     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.12.004     Document Type: Article

References (27)

1. Benowitz N.L. The role of nicotine in smoking-related cardiovascular disease. Prev. Med. 1997, 26:412-417.
2. Berg C.J., et al. Cigarette users' interest in using or switching to electronic nicotine delivery systems or smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults. Nicotine Tob. Res. 2015, 17:245-255.
3. Bullen C., et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob. Control 2010, 19:98-103.
4. Caponnetto P., et al. EffiCiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013, 8:e66317.
5. Cox L.S., et al. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res. 2001, 3:7-16.
6. Dawkins L., Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacol. Berl. 2014, 231:401-407.
7. Dockrell M., et al. E-Cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob. Res. 2013, 15:1737-1744.
8. EMA, European Medicines Agency Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence 2010, Last accessed 23.10.2015. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf.
9. Etter J.F., Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011, 106:2017-2028.
10. Farsalinos K.E. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes 2012, ESC Congress, Munich.
11. Farsalinos K.E., et al. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int. J. Environ. Res. Public Health 2014, 11:4356-4373.
12. Farsalinos K.E., et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci. Rep. 2014, 4:4133.
13. Flouris A.D., et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal. Toxicol. 2013, 25:91-101.
14. Flouris A.D., et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem. Toxicol. 2012, 50:3600-3603.
15. HC, Health Canada Guidance Document. Conduct and Analysis of Comparative Bioavailability Studies 2012, Last accessed 23.10.15. http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/prodpharma/applic-demande/guide-ld/bio/gd_cbs_ebc_ld-eng.pdf.
16. Heatherton T.F., et al. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
17. Hughes J.R. Measurement of the effects of abstinence from tobacco: a qualitative review. Psychol. Addict. Behav. 2007, 21:127-137.
18. MHRA Licensing Procedure for Electronic Cigarettes and Other Nicotine Containing Products (NCPs) as Medicines 2015, Last accessed 23.10.15. http://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con297583.pdf.
19. Moyses C., et al. Evaluation of a novel nicotine inhaler device: part 2-effect on craving and smoking urges. Nicotine Tob. Res. 2015, 17:26-33.
20. Polosa R., et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg. Med. 2014, 9:537-546.
21. Roche Cobas b 221 blood gas analyser system 2009, Instructions for use. Roche Reference Number 03261395001, Roche Diagnostics, Charles Avenue, Burgess Hill, West Sussex, UK.
22. Spindle T.R., et al. Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob. Res. 2015, 17:142-149.
23. van Staden S.R., et al. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S Afr. Med. J. 2013, 103:865-868.
24. Vansickel A.R., et al. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomarkers Prev. 2010, 19:1945-1953.
25. Vansickel A.R., Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob. Res. 2013, 15:267-270.
26. Vardavas C.I., et al. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012, 141:1400-1406.
27. Walele T., et al. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A Pharmacokinetics Regul. Toxicol. Pharmacol. 2016, 74:187-192.